baber/WOPTO huggingface dataset:
Patent AU-600883-B2 (AU)
Title: Buffered silane emulsions for rendering porous substrates water repellent
Inventor: WILSON MICHAEL EARL
IPC: C04B41/49
Filed: 1989-01-24
Granted: 1990-08-23
Abstract: There are provided aqueous emulsions useful for rendering porous substrates water repellent comprising (a) a hydrolyzable silane having a determinable pH-stable range, (b) an emulsifying agent having an HLB value of from 2 to 20, an effective amount of (c) a buffering compound to maintain the composition within the pH-stable range; and (d) water. Such buffered compositions are stable on long term storage and maintain high effective levels of active silane content even when they include biocides which may accelerate the hydrolysis of aqueous silane-containing compositions.
Patent AU-662367-B2 (AU)
Title: Phospholipid antimicrobial compositions
Inventor: FOST DENNIS L
IPC: A61K38/00
Filed: 1992-10-28
Granted: 1995-08-31
Abstract: There is provided antimicrobial agents which exhibit broad spectrum antibacterial, antifungal, spermicidal and virucidal activity of formula (I) wherein x = 1 to 3 or mixtures thereof; x + y = 3; z = x; a = 0 to 2; B = O<-> or OM; A = an anion; M is a cation; R, R1 and R2 are the same or different and are alkyl, substituted alkyl, alkyl aryl or alkenyl groups of up to 16 carbon atoms with the proviso that the total carbon atoms in R + R1 + R2 is between 10 and 24.
Patent AU-770642-B2 (AU)
Title: Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity
Inventor: BENEDINI FRANCESCA
IPC: A61P29/00
Filed: 2000-02-23
Granted: 2004-02-26
Abstract: Organic or inorganic salts of compounds of general formula: A-X1-N(O)z for use as medicaments having anti-inflammatory, analgesic and antithrombotic activity, wherein A is R(COXu)t wherein t is 0 or 1; u is 0 or 1 and X is O, NH, NR1c wherein R1c us a C1-C10 alkyl and R is, for example, (Ia) wherein R1 is acetoxy, preferably in ortho position with respect to -CO- and R2 is hydrogen or acetylsalicylsalicylic acid derivatives; and X1 is the formula (B), Y being a ring containing at least one salified nitrogen atom.
Patent AU-685999-B2 (AU)
Title: A flow control device for the outlet nozzle of a metallurgical vessel
Inventor: DAINTON ALBERT EDWARD
IPC: B22D41/48
Filed: 1995-08-16
Granted: 1998-01-29
Abstract: PCT No. PCT/GB95/01934 Sec. 371 Date Mar. 5, 1997 Sec. 102(e) Date Mar. 5, 1997 PCT Filed Aug. 16, 1995 PCT Pub. No. WO96/07495 PCT Pub. Date Mar. 14, 1996A flow control device for the outlet nozzle for a molten metal handling vessel, such as a ladle, includes a plug that fits in the outlet nozzle to define a gap between the plug and a closure for the nozzle. The plug has a plurality of apertures which are closed by steel plates, or other material, that melts under the influence of the molten metal in the vessel. When molten metal is placed into the vessel and the closure for the outlet is opened, the molten metal flows into the apertures, melting the meltable material in the apertures, and out the outlet. Using a device and method described allows the amount of molten metal in a ladle to be reduced to about 0.5%, and a greater than 99% free opening rate can be provided.
Patent AU-666912-B2 (AU)
Title: Cosmetic composition
Inventor: MAY SHANA A
IPC: A61Q5/02
Filed: 1993-02-05
Granted: 1996-02-29
Abstract: A liquid, aqueous shampoo composition, e.g. a hair or body shampoo, comprises:   (a) as a principal surfactant component, at least one alkyl polyglycoside; and (b) at least one short chain fatty acid soap having a carbon chain length of up to C16, preferably C8 to C12.
Patent AU-766675-B2 (AU)
Title: Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
Inventor: MURPHY GERALD P
IPC: C07K16/28
Filed: 1999-03-29
Granted: 2003-10-23
Abstract: The present invention relates to the identification of a novel role of CXCR-4 in cell transformation and aberrant cellular proliferation. In particular, the present invention relates to the altered gene expression of CXCR-4 in a number of primary tumors and cell lines derived from tumors, in addition to, the altered gene expression of ligands for CXCR-4. Further, the present invention relates, in part, to the Applicants' surprising discovery that the inhibition of CXC R- 4 gene expression or the inhibition of CXCR-4 activity in transformed cells reverses the transformed phenotype.
Patent AU-620622-B2 (AU)
Title: Novel derivatives and processes for the production thereof
Inventor: UMEZAWA SUMIO
IPC: A61K31/7048
Filed: 1989-06-13
Granted: 1992-02-20
Abstract: 3-Deoxy mycaminosyl tylonolide derivatives represented by the following general formula and salts thereof: <CHEM> wherein X represents an oxygen atom or =N-OR<4> (wherein R<4> represents hydrogen or lower alkyl); R<1> represents a hydrogen atom, an acyl group or an alkylsilyl group; R<2> represents a hydrogen atom or an acyl group; and R<3> represents a hydrogen atom or a hydroxyl group. The compounds of formula (I) have excellent antibacterial activity.
Patent AU-684457-B2 (AU)
Title: Electronic marking instrument
Inventor: HASTINGS NICHOLAS J
IPC: G01P13/00
Filed: 1993-03-03
Granted: 1997-12-18
Abstract: PCT No. PCT/GB93/00440 Sec. 371 Date Dec. 27, 1994 Sec. 102(e) Date Dec. 27, 1994 PCT Filed Mar. 3, 1993 PCT Pub. No. WO93/17872 PCT Pub. Date Aug. 16, 1993.A hand-held marking device comprises an electrically actuated writing head for making marks on a writing surface and a sensor for detecting when the writing head is moving in any direction in a plane parallel to the surface. The device includes a mechanism for causing the head to be actuated when the sensor detects relative movement of the writing head and the surface. The writing head can be arranged to be able to make a plurality of different types or sizes of marks on a writing surface, in which case a mechanism is provided for selecting which of the different mark types or sizes is to be made.
Patent AU-760283-B2 (AU)
Title: Prefabricated finishing module for the construction of building constructions and building constructions obtained thereby
Inventor: LUCHINI CLAUDIO
IPC: E04B2/86
Filed: 1999-05-19
Granted: 2003-05-08
Abstract: A prefabricated finishing module for the construction of building constructions provided with at least one pair of panels facing one another, bounding a space for the casting of concrete, adapted to be connected to one another and to respective panels of adjacent modules and each bounded by first edges opposite one another and by second edges opposite one another and extending between respective ends of the first edges. The module is characterized in that the first edges of each panel have respective first longitudinal grooves aligned with one another and in that the second edges have respective second longitudinal grooves aligned with one another, intersecting the first grooves and transversely offset with respect to first grooves; the first and second grooves are engaged in use, at least in part, by respective first and second anchors adapted to connect the module to adjacent modules intersecting one another reciprocally.
Patent AU-762251-B2 (AU)
Title: Syringe pumps
Inventor: FORD ANDREW JOHN
IPC: A61M5/168
Filed: 2000-06-30
Granted: 2003-06-19
Abstract: Syringe pump has plunger head retainer (10) with two retainer arms (111 and 112) mounted on shafts (113 and 114) extending parallel to the syringe axis. Each shaft carries gear (121 and 122), which is engaged by common gear wheel (142) mounted on threaded shaft (146). After the syringe (3) has been loaded in the pump, the plunger head retainer (10) is driven forwards until a pad (107) coupled with a force sensor (108) detects contact with the head (36). This causes the retainer arms to be swung in across the forward side of the plunger head (36) and to be pulled rearwardly against the plunger head. The pump then reduces the force applied by the retainer arms to ensure that the force sensor (108) can respond to force on the plunger (35) during expulsion of liquid from the syringe.  <IMAGE>
Patent AU-635912-B2 (AU)
Title: Method for the treatment of periodontal disease by sustained delivery of a pharmaceutical agent to the crevicular pocket, composition of matter therefor and apparatus for the administration thereof
Inventor: BRIZZOLARA NANCY SUSAN
IPC: A61K9/50
Filed: 1989-12-21
Granted: 1993-04-08
Abstract: Oral compositions for the local administration of a therapeutic agent to a periodontal pocket of a patient for alleviating dental disease comprise a plurality of dry, discrete microparticles each of which comprise an effective amount of at least one therapeutic agent dispersed in a matrix comprising a biocompatible and biodegradable polymer. Apparatus and methods are also provided for the dispensing of the dry microparticles to the periodontal pocket whereby they become tacky and adhere to the involved tissue so as to induce long term therapeutic benefits.
Patent AU-732421-B2 (AU)
Title: Spinal spacer
Inventor: PAFFORD JOHN
IPC: A61L27/18
Filed: 1997-10-21
Granted: 2001-04-26
Abstract: Spinal spacers (20) are provided for fusion of a motion segment. The spacers include a load bearing member (21) having a wall (22) sized for engagement within a space between adjacent vertebrae to maintain the space and an effective amount of an osteogenic composition (30) to stimulate osteoinduction. The osteogenic composition includes a substantially pure osteogenic factor in a pharmaceutically acceptable carrier. In one embodiment the load bearing member includes a bone graft impregnated in an osteogenic composition. In another embodiment, the osteogenic composition (30) is packed within a chamber (25) defined in the graft. Any suitable configuration of a bone graft is contemplated, including bone dowels, D-shaped spacers and cortical rings. <IMAGE>
Patent AU-716239-B2 (AU)
Title: Liquefaction handpiece
Inventor: CAPETAN THOMAS G
IPC: A61B18/04
Filed: 1997-10-29
Granted: 2000-02-24
Abstract: A surgical handpiece having at least two lumens mounted to a body. One lumen is used for aspiration, the second lumen is used to inject heated surgical fluid for liquefying a cataractous lens. A portion of the second lumen is surrounded by an insulated heating element that heats the surgical fluid as it passes through the second lumen. The handpiece may also contain a device for delivering the surgical fluid through the second lumen in metered pulses of a defined volume.
Patent AU-695854-B2 (AU)
Title: Aluminium alloy powder blends and sintered aluminium alloys
Inventor: SCHAFFER GRAHAM BARRY
IPC: C22C1/05
Filed: 1996-05-02
Granted: 1998-08-27
Abstract: PCT No. PCT/AU96/00256 Sec. 371 Date Oct. 31, 1997 Sec. 102(e) Date Oct. 31, 1997 PCT Filed May 2, 1996 PCT Pub. No. WO96/34991 PCT Pub. Date Nov. 7, 1996The invention relates to an aluminum powder blend and sintered components produced from the aluminum powder blend. The powder is based on the precipitation hardenable 7000 series Al-Zn-Mg-Cu alloys with trace addition of lead or tin. The powder blend comprises 2-12 wt. % zinc, 1-5 wt. % magnesium, 0.1-5.6 wt. % copper, 0.01-0.3 wt. % lead or tin, and the balance aluminum. The invention also provides a composite powder comprising the foregoing powder blend and a reinforcing element or compound.
Patent AU-628172-B2 (AU)
Title: Antirhinoviral piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers
Inventor: STOKBROEKX RAYMOND ANTOINE
IPC: C07D285/08
Filed: 1990-05-10
Granted: 1992-09-10
Abstract: Piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers of formula <CHEM> X is N or CH; Alk is C1-4alkanediyl; R<1> and R<2> are hydrogen, C1-4alkyl or halo; R<3> is hydrogen, halo, cyano, C1-4alkyloxy, aryl or -COOR<4>, with R<4> being hydrogen, C1-4alkyl, arylC1-4alkyl, C3-6cycloalkylC1-4alkyl, C3-5alkenyl, C3-5alkynyl or C1-4alkyloxyC1-4alkyl; or R<3> is a radicai of formula <CHEM> the addition salts and stereochemically isomeric forms thereof, said compounds having antirhinoviral activity. Pharmaceutical compositions containing these compounds as active ingredient, and a method of preparing said compounds and pharmaceutical compositions.
Patent AU-683032-B2 (AU)
Title: Flanging apparatus particularly for hollow articles obtained by thermoforming sheet material
Inventor: PADOVANI PIETRO
IPC: B29C51/18
Filed: 1993-10-27
Granted: 1997-10-30
Abstract: Flanging or curling apparatus particularly for hollow articles (15) obtained by thermoforming from thermoformable sheet material for use in a thermoforming plant equipped with template or mask conveyor (4) for transfer of the thermoformed objects (15). The apparatus comprises a support frame (2) which delimits at least one workstation for a sequence of masks (3) supporting hot thermoformed objects (15) carried by the conveyor (4) or at least one head for simultaneous curling of all thermoformed objects (15) in the or each workstation.
Patent AU-707942-B2 (AU)
Title: New vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents
Inventor: KIRSCH GERALD
IPC: C07C401/00
Filed: 1996-04-30
Granted: 1999-07-22
Abstract: A method of preparing a pharmaceutical composition, comprising combining a pharmaceutically compatible vehicle with a compound according to formula (I)
Patent AU-708777-B2 (AU)
Title: Vaccine composition comprising polyribosylribitol phosphate and method for its manufacture
Inventor: ARMINJON FRANCOIS
IPC: A61K39/385
Filed: 1996-05-24
Granted: 1999-08-12
Abstract: Vaccine compositions are disclosed which comprise at least one antigen formed by the capsular polysaccharide of Haemophilus influenzae type b or high molecular weight polyribosylribitol phosphate coupled to tetanus anatoxin.
Patent AU-642423-B2 (AU)
Title: Sequence of anti-direction, anti-messenger RNA oligonucleotides of alpha TNF, preparation process, use as medicaments and pharmaceutical compositions
Inventor: BRAHAM ABDEL KARIM
IPC: C12N15/28
Filed: 1990-08-22
Granted: 1993-10-21
Abstract: The application relates to an anti-sense oligonucleotide sequence which is an anti-RNA against TNF alpha messenger RNA, of formula (I): TCA TGG TGT CCT TTG CAG-X (I> in which X represents hydrogen or a sequence of 1 to 17 oligonucleotides in free, alkylated or sulphur-containing form or in the form of poly-L-lysine derivatives, process for the preparation thereof, medical use thereof and pharmaceutical preparations containing this novel sequence.
Patent AU-630236-B2 (AU)
Title: Hydrophilic laminated porous membranes and methods of preparing same
Inventor: CHING SHAN FUN
IPC: G01N33/548
Filed: 1990-09-26
Granted: 1992-10-22
Abstract: Laminated porous membranes useful in chromatographic assay devices include nitrocellulose or polyvinylidene difluoride (PVDF) membranes laminated to supports. Despite lamination, the membranes remain wettable and the activity of biologically reactive reagents is not impaired due to the use of water based adhesives in making the laminates. Water based adhesives include AS73 from Adhesive Research, Inc, polyvinylacetate (PVA) and polyvinylpyrrolidone (PVP) among others.
Patent AU-774766-B2 (AU)
Title: Amplification method for detection of target nucleic acids involving fluorescence energy transfer
Inventor: LEE MARTIN ALAN
IPC: C12Q1/6853
Filed: 2000-08-03
Granted: 2004-07-08
Abstract: A method for detecting the presence of a target nucleic acid sequence in a sample, said method comprising subjecting said sample to an amplification reaction using a set of nucleotides, at least one of which is labelled with a first label, and a reagent comprising an amplification primer which can hybridise to said target sequence when in single stranded form and which is connected at its 5' end to a probe which carries a second label by way of a chemical linking group, said labelled probe being of a sequence which is similar to that of the said target sequence, such that it can hybridise to a complementary region in an amplification product, and wherein one of the first or the second label comprises a donor label and the other comprises an acceptor label, the donor label comprising a fluorescent molecule which is able to donate fluorescent energy to the acceptor label; and monitoring fluorescence of said sample. The method can be used to quantitate the amount of target nucleic acid in the sample as well as to determine sequence characteristics. Kits for effecting the method are also claimed.
Patent AU-782102-B2 (AU)
Title: Identification of genetic markers of biological age and metabolism
Inventor: WEINDRUCH RICHARD H
IPC: C12Q1/68
Filed: 2000-08-08
Granted: 2005-07-07
Abstract: A method of measuring the biological age of a multicellular organism is disclosed. In one embodiment this method comprises the steps of obtaining a sample of nucleic acid isolated from the organism's organ, tissue or cell and determining the expression pattern of a panel of sequences within the nucleic acid that have been predetermined by either increase or decrease in response to biological aging of the organ, tissue or cell. A method of obtaining biomarkers of aging is also disclosed. This method comprises the step of comparing a gene expression profile of a young multicellular organism subject's organ, tissue or cells; a gene expression profile from a chronologically aged subject's organ, tissue or cell; and a gene expression profile from a chronologically aged but biologically younger subject's organ, tissue or cell and identifying gene expression alterations that are observed when comparing the young subjects and the chronologically aged subjects and are not observed or reduced in magnitude when comparing the young subjects and the chronologically aged but biologically younger subjects.
Patent AU-596129-B2 (AU)
Title: Blends of polyethylene
Inventor: KIM YONG JOO
IPC: B32B27/32
Filed: 1986-11-27
Granted: 1990-04-26
Abstract: Polyethylene blends are disclosed suitable for packaging and have two components, polyethylene or LLDPE and, as the second component, an ethylene butene-1 copolymer. A third component may be present in the blends, the third component being an elastomer. The ethylene butene-1 copolymer is prepared from a combination of 81 to 94 mole% ethylene and 19 to 6 mole % butene-1.
Patent AU-780319-B2 (AU)
Title: Simultaneous isolation and quantitation of DNA
Inventor: TEREBA ALLAN M
IPC: C12Q1/68
Filed: 2000-08-18
Granted: 2005-03-17
Abstract: The present invention provides methods for isolating a defined quantity of DNA target material from other substances in a medium. The method may be carried out using a known quantity of a silica-containing solid support, such as silica magnetic particles, having a definable capacity for reversibly binding DNA target material, and DNA target material in excess of the binding capacity of the particles. The methods of the present invention involve forming a complex of the silica magnetic particles and the DNA target material in a mixture of the medium and particles, and separating the complex from the mixture using external magnetic force. The DNA target material may then be eluted from the complex. The quantity of DNA target material eluted may be determined based on a calibration model. The methods of the present invention permit isolation of DNA target material which is within a known quantity range. The methods of the invention eliminate the step of quantitating purified biological samples prior to further processing, such as amplification, Short Tandem Repeat (STR) analysis, and DNA sequencing. Samples of the DNA target materials may be obtained from liquid or solid media, such as liquid blood or paper.
Patent AU-766475-B2 (AU)
Title: Apparatus and method for removing solvent residues
Inventor: CORR STUART
IPC: B01D5/00
Filed: 2000-08-31
Granted: 2003-10-16
Abstract: In the field of biomass extraction, there is a need for effective removal of solvent from spent biomass material. An apparatus for removing solvent residues includes a vessel ( 11 ) for containing biomass; a steam source ( 19 ) for supplying steam to contact the biomass; and a separator ( 24 ) for separating solvent from steam that has contacted the biomass. The disclosure also includes a method of use of the apparatus.
Patent AU-591772-B2 (AU)
Title: Substituted oxime-ethers and their use as bioregulators to lower the endogenous ethylene level in plants
Inventor: SCHULZ GUENTER
IPC: A01N35/10
Filed: 1987-04-21
Granted: 1989-12-14
Abstract: Substituted oxime-ethers of the formulae    <IMAGE>  (Ia)   <IMAGE> (Ib)  where R1 and R2 independently of one another are C1-C6-alkyl, n is 2 or 3 and R3 is hydrogen or C1-C6-alkyl.
Patent AU-587131-B2 (AU)
Title: Vulcanization sleeve for repairing or retreading vehicle tyres
Inventor: SCHMERMBECK DIETER
IPC: B29D30/56
Filed: 1987-05-16
Granted: 1989-08-03
Abstract: The vulcanization sleeve described is designed to be air-tight at least in the tyre processing region to allow evacuation of air and gaz bubbles from the space between the sleeve and the tyre or the tread or tread cap, and it covers the processing region during vulcanization in an autoclave. The problem is to find a solution which while maintaining the advantages of the so-called cold process enables during vulcanization a considerable increase in the longevity of the sleeves, a simplification in handling and in particular the application by vulcanization of treads in the form of sections of otherwise endless pieces of tread. This is achieved by the fact that the vulcanization sleeve is made of a plastic foil (6) of thermoplastic polyurethane, and in the event of a partial covering of the tyre, this sleeve is provided possibly with a sealing ring (7).
Patent AU-679560-B2 (AU)
Title: Galanthamine derivatives, a process for their preparation and their use as medicaments
Inventor: KOSLEY RAYMOND W JR
IPC: C07D491/06
Filed: 1994-10-14
Granted: 1997-07-03
Abstract: A compound of the formula (II) <CHEM>  wherein   R<1> is (C1-C12)alkylcarbonyl, (C1-C12)alkoxycarbonyl, mono(C1-C12)alkylaminocarbonyl, or di(C1-C12)alkylaminocarbonyl; R<2> is mono(C1-C12)alkylaminocarbonyloxy, di(C1-C8)alkylaminocarbonyloxy, or aryl(C1-C4)alkylaminocarbonyloxy; R<3> is hydrogen, halo or (C1-C4)alkyl; or a pharmaceutically acceptable acid addition salt thereof.
Patent AU-634657-B2 (AU)
Title: Use of substituted 1,2,4-triazinediones
IPC: A61K31/53
Filed: 1991-05-17
Granted: 1993-02-25
Abstract: The present invention relates to the use of substituted 1,2,4-triazinediones of the general formula (I) 
<IMAGE>
 in which 
 
  R<1> is optionally substituted pyridyl, pyrazinyl or pyrimidinyl, 
  X is O, S, SO, SO2 or -CR<4)<CN)-, 
  R<2> is hydrogen, one or more identical or different radicals from the group comprising hydrogen, halogen, nitro, alkyl, alkoxy, alkylthio, halogenoalkyl, halogenoalkoxy, alkylthio, halogenoalkylthio, 
  R<3> is hydrogen, optionally substituted alkyl, alkenyl, alkynyl, aralkyl, 
  R<4> is hydrogen or alkyl, 
 for controlling parasitic protozoa.
Patent AU-547993-B2 (AU)
Title: Linking bar support for making a link by adherance of construction parts
Inventor: PATTISELANNO J
IPC: E04G21/12
Filed: 1981-11-03
Granted: 1985-11-14
Abstract: PCT No. PCT/CH81/00119 Sec. 371 Date Aug. 19, 1982 Sec. 102(e) Date Aug. 19, 1982 PCT Filed Nov. 3, 1981 PCT Pub. No. WO82/02223 PCT Pub. Date Jul. 8, 1982.The holder exhibits a basic part (16), consisting of a bottom part (5) and two longitudinal side parts (6), and a flexible cover part (7). The individual parts (5, 6, 7) of the holder are detachably interconnected by means of snap fasteners (8). The cover part (7) is provided with opposing slots (11) extending from its longitudinal edges. Second sections (14b) of the connecting bars (14) are introduced into the slots (11), the slots (11) closely surrounding the second sections (14b) of the connecting bars (14). The individual parts (5, 6, 7) are easy to assemble and disassemble. At least the longitudinal side parts (6) are reusable. By means of snap fasteners (8), a simple detachable connection of the parts (5, 6, 7) is provided.